User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 13 results.
    • Speech
    A prospective one year randomized comparative clinical and MRI study of the effects of methotrexate (MTX) alone or in combination with infliximab (IFX) or intravenous (IV) pulse methylprednisolone (MP) in early rheumatoid arthritis (RA)
    Durez, Patrick[UCL] Malghem, Jacques[UCL] Lauwerys, Bernard[UCL] Houssiau, Frédéric[UCL] Toukap, A. Nzeusseu Depresseux, Geneviève[UCL] Westhovens, Rene[UCL] Luyten, F. P. Verschueren, P. (2006) Annual European Congress of Rheumatology (EULAR 2006) — Amsterdam (Netherlands)
    • Speech
    How to evaluate the DAS28 in patients with a false high score for reasons other than rheumatoid arthritis disease activity?
    Cruyssen, B. Vander Durez, Patrick[UCL] Van den Bosch, F. Westhovens, Rene[UCL] Mielants, H. DeKeyser, F. (2006) Annual European Congress of Rheumatology (EULAR 2006) — Amsterdam (Netherlands)
    • Speech
    Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition.
    Cruyssen, Bert J. Vander Durez, Patrick[UCL] Westhovens, Rene Van den Bosch, Filip Mielants, Herman De Clerck, Luc Peretz, Ann Malaise, Michel Verbruggen, Leon Vastesaeger, Nathan Geldhof, Anja De Keyser, Filip (2006) 70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — Washington (Dc)
    • Speech
    Detection of vertebral fractures on routine chest rays: The stof study
    Goemaere, S. Durez, Patrick[UCL] Devogelaer, Jean-Pierre[UCL] Boutsen, Yves Vanslembrouck, J. Nisolle, Jean-François[UCL] Verstraete, K. Kaufman, J. M. (2006) 11th Conference of the National-Osteoporosis-Society — Harrogate (England)
    • Speech
    Lack of efficacy with 3 oral dose levels of TMI-005 (Apratastat), in subjects with active rheumatoid arthritis on a background of methotrexate-A phase 2 double-blind, placebo-controlled, parallel, randomized study
    Fleischman, R. Durez, Patrick[UCL] Genovese, M. Keystone, E. M. Pavelka, L. Pavlik-Gaylord, S. Kirsch, T. M. Sridharan, S. (2006) Annual European Congress of Rheumatology (EULAR 2006) — Amsterdam (Netherlands)
    • Speech
    One-year results of golimumab compared with placebo in patients with active RA despite treatment with methotrexate: A phase II, randomized, double-blind, placebo-controlled, dose-ranging trial.
    Kay, J. Durez, Patrick[UCL] Matteson, E. L. Dasgupta, B. Nash, P. Hall, S. Hsia, E. C. Chiruvolu, P. Han, J. Rahman, M. U. (2006) 70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — Washington (Dc)
    • Speech
    Long-term safety of infliximab (INX) with methotrexate (MTX) in a large belgian observational patient cohort with severe, refractory rheumatoid arthritis (RA)
    Durez, Patrick[UCL] Devogelaer, Jean-Pierre[UCL] Vander Cruyssen, B. Vandenbosch, F. Vastesaeger, N. Geldhof, A. De Keyser, F. Verbruggen, L. De Clerck, L. Peretz, A. Malaise, Michel Van Heuverbeke, F. Westhovens, Rene[UCL] (2006) Annual European Congress of Rheumatology (EULAR 2006) — Amsterdam (Netherlands)
    • Speech
    Oral glucocorticoids have no impact on the efficacy or safety profile of rituximab in rheumatoid arthritis patients with inadequate response to TNF inhibitors (REFLEX study)
    Burmester, G. R. Durez, Patrick[UCL] Ruderman, E. M. Loveless, J. Kvien, T. K. Jackson, C. Burke, L. Cravets, M. White, A. M. (2006) Annual European Congress of Rheumatology (EULAR 2006) — Amsterdam (Netherlands)
    • Journal article
    Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
    Cruyssen, Bert Vander Van Looy, Stijn Wyns, Bart Westhovens, Rene Durez, Patrick[UCL] Van den Bosch, Filip Mielants, Herman De Clerck, Luc Peretz, Ann Malaise, Michel Verbruggen, Leon Vastesaeger, Nathan Geldhof, Anja Boullart, Luc De Keyser, Filip (2006) Arthritis Research & Therapy (Online) — Vol. 8, no. 4, p. R112 [1-7] (2006)
    • Journal article
    Response to the commentary 'Pooled indices to measure rheumatoid arthritis activity: a good reflection of the physician's mind'
    Vander Cruyssen, Bert Durez, Patrick[UCL] Westhovens, Rene Vastesaeger, Nathan Geldhof, Anja De Keyser, Filip (2006) Arthritis Research & Therapy (Online) — Vol. 8, no. 6, p. 406 [1-2] (2006)
    • Speech
    Evaluation of the DAS28 at week 14 or week 22 correlates best with long term attrition to infliximab therapy in rheumatoid arthritis patients
    Cruyssen, B. Vander Durez, Patrick[UCL] Van Looy, S. Wijns, B. Westhovens, Rene[UCL] Van den Bosch, F. Mielants, H. De Clerck, L. Peretz, A. Malaise, Michel Verbruggen, L. Vastesaeger, N. Geldhof, A. Boullart, L. De Keyser, F. (2006) Annual European Congress of Rheumatology (EULAR 2006) — Amsterdam (Netherlands)
    • Speech
    Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Attrition and long-term clinical effect
    Cruyssen, B. Vander Durez, Patrick[UCL] Westhovens, Rene[UCL] Van den Bosch, F. Mielants, H. De Clerck, L. Peretz, A. Malaise, Michel Verbruggen, L. Vastesaegere, N. Geldhof, A. De Keyser, F. (2006) Annual European Congress of Rheumatology (EULAR 2006) — Amsterdam (Netherlands)
    • Speech
    Oral glucocorticoids have no impact on the efficacy or safety profile of rituximab in rheumatoid arthitis (RA) patients with inadequate response to TNF inhibitors (REFLEX study).
    Ruderman, E. M. Durez, Patrick[UCL] Burmester, G. R. Loveless, J. Kvien, T. K. Jackson, C. Burke, L. Cravets, M. White, A. M. (2006) 70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — Washington (Dc)